Search

Search Results

1. Systematic review of long-term effectiveness of endoscopic gastrojejunostomy in patients presenting with gastric outlet obstruction from periampullary malignancies

   Background

   Recently, endoscopic ultrasound-guided (EUS) gastrojejunostomy (GJ) has emerged as an alternative option to surgical palliation and...

   William Cobb, Shelby Harris, ... Sebastian G. de la Fuente in Surgical Endoscopy

   Article 17 June 2024
   

2. COVID-19 Effect on Surgery for Gastrointestinal Malignancies: Have Operative Volumes Recovered?

   Background

   COVID-19 disrupted elective operations, cancer screening, and routine medical care while simultaneously overwhelming hospital staff and...

   Alexander Manzella, Mariam F. Eskander, ... Henry A. Pitt in Journal of Gastrointestinal Surgery

   Article 25 September 2023
   

3. Gastrointestinal malignancies in pregnancy

   Gastrointestinal malignancies, though uncommon in pregnancy, present several unique challenges with regards to diagnosis, staging, and treatment....

   Melina Pectasides, Aarti Sekhar, ... Jeanne M. Horowitz in Abdominal Radiology

   Article 06 January 2023
   

4. Gastric perforation biopsy: is it obsolete?

   Purpose

   The aim of the study was to test the established hypothesis that biopsies of spontaneous gastric perforations should be taken to rule out...

   Petre Francois Steyn, Otto Karusseit in Langenbeck's Archives of Surgery

   Article Open access 27 April 2024

5. Immunotherapy for GI Malignancies, Ready for Prime Time?

   Gastrointestinal (GI) cancers include esophageal, gastric, pancreatic, hepatobiliary, and colorectal malignancies. Immunotherapy has proved to be an...

   Andrew D. Tieniber, Juanes E. Perez, ... Ronald P. DeMatteo in Annals of Surgical Oncology

   Article 22 October 2022
   

6. Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies

   Malignancies of the peritoneal cavity are associated with a dismal prognosis. Systemic chemotherapy is the gold standard for patients with...

   Niels A. D. Guchelaar, Bo J. Noordman, ... Ron. H. J. Mathijssen in Drugs

   Article Open access 12 January 2023
   

7. Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies

   Treating metastatic malignancies to the central nervous system (CNS) is challenging because many drugs cannot cross the blood-brain-barrier (BBB)....

   Trevor Jamison, Emaan Haque, ... Mahmoud Aljurf in Medical Oncology

   Article 17 June 2024

8. The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies—experience from a tertiary care center in Germany

   Purpose

   Peritoneal surface malignancies (PSM) are commonly known to have a dismal prognosis. Over the past decades, novel techniques such as...

   Mikko Reese, Ann-Kathrin Eichelmann, ... Judith C. Sporn in Langenbeck's Archives of Surgery

   Article 08 April 2024
   

9. Adenocarcinoma of the Gastro-jejunal Anastomosis After One Anastomosis Gastric Bypass

   Introduction

   One anastomosis gastric bypass (OAGB) is mainly criticized for the supposed carcinogenic effect of bile reflux on the gastric pouch...

   Christian Mouawad, Houssam Dahboul, ... Ghassan Chakhtoura in Journal of Gastrointestinal Cancer

   Article 10 September 2023
   

10. Targeting Angiogenesis Alone and in Combination with Immune Checkpoint Inhibitors in Advanced Gastroesophageal Malignancies

    Purpose of Review

    This review critically examines the latest approaches in treating advanced gastroesophageal malignancies. It emphasizes the...

    Alireza Tojjari, Robin Park, ... Anwaar Saeed in Current Gastroenterology Reports

    Article 31 January 2024
    

11. Nephrotic syndrome associated with solid malignancies: a systematic review

    Background

    Nephrotic syndrome (NS) can occur as a paraneoplastic disorder in association with various types of carcinoma. However, paraneoplastic...

    Shuo Liu, Yuchen Wan, ... Fenye Liu in BMC Nephrology

    Article Open access 04 July 2024
    

12. Treatment strategy for HER2-negative advanced gastric cancer: salvage-line strategy for advanced gastric cancer

    After immune checkpoint inhibitor (ICI) comes into third-line treatment of advanced gastric cancer, the therapeutic strategy has been dramatically...

    Naohiro Nishida, Daisuke Sakai, Taroh Satoh in International Journal of Clinical Oncology

    Article Open access 11 May 2024
    

13. Effects of Cyclooxygenase-2 Inhibitors on Gastrointestinal Malignancies: a Systematic Review and Meta-analysis

    Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with a reduced risk of gastrointestinal malignancies, which is thought to be...

    Yuan-** Jiang, Ying Chen, ... Shu-chang Xu in Indian Journal of Surgical Oncology

    Article 10 May 2022
    

14. Metastatic gastric adenocarcinoma with appendiceal phlegmon: a case report

    Background

    Gastric carcinoma is one of the most frequent malignancies worldwide. Gastric cancer metastasis to the appendix is uncommon in incidence,...

    Farshid Mohammadi, Mehta Razzaghi, ... Ehsan Amjadinia in Journal of Medical Case Reports

    Article Open access 27 February 2023
    

15. A large-scale, observational study to investigate the current status of diabetes complication and their prevention in Japan: incidence/risk factors for malignancies during follow-up—JDCP study 11 (English version)

    In the large-scale, prospective, observational JDCP study, a total of 5944 people with type 2 diabetes (mean age at baseline, 61.4 years old; women,...

    Kenji Yamashiro, Hiroshi Takahashi, ... Rimei Nishimura in Diabetology International

    Article 23 May 2024
    

16. ASO Author Reflections: Applications of Artificial Intelligence in Oesophago-Gastric Malignancies—Present Work and Future Directions

    Our paper highlights the use of artificial intelligence (AI) in oesophageal and gastric malignancies with acceptable levels of accuracy for both...

    Swathikan Chidambaram, Viknesh Sounderajah, ... Sheraz R. Markar in Annals of Surgical Oncology

    Article Open access 18 November 2021

17. Upper and Lower Eyelid Malignancies: Differences in Clinical Presentation, Metastasis, and Treatment

    Approximately 5–15% of all dermatologic malignancies manifest in the upper and lower eyelids. The primary types include basal cell carcinoma,...

    M. Mukarram, A. Khachemoune in Archives of Dermatological Research

    Article 22 June 2024
    

18. Progression of pancreatic branch duct-type intraductal papillary mucinous neoplasms (BD-IPMNs) after surgery for extrapancreatic malignancies

    Background/aims

    The natural history of pancreatic branch duct-type intraductal papillary mucinous neoplasms (BD-IPMNs) is still unknown. This...

    Akira Imoto, Takeshi Ogura, ... Usama M. Abdelaal in Egyptian Liver Journal

    Article Open access 25 October 2023

19. Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing

    Recently, the results of gastric cancer treatment have improved; however, its characteristics in adolescents and young adults are not well known. We...

    Tsutomu Namikawa, Tomoki Tanaka, ... Satoru Seo in Clinical Journal of Gastroenterology

    Article 07 November 2023
    

20. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies

    Targeted therapy with Bruton tyrosine kinase (BTK) inhibitors have revolutionized the treatment of patients with various B-cell malignancies. BTK...

    Yuqin Song, Shang-Ju Wu, ... Eric Wai Choi Tse in Experimental Hematology & Oncology

    Article Open access 16 October 2023